Liver Transplants Assisted Colorectal Cancer Patients
A study showed long-term survival outcomes for adults who received transplants for unresectable liver metastases.
Updated on Oct. 13, 2026 in Cancer
Live Poll
Should specialized transplant treatments for rare cancers receive broader focus in national healthcare?
A retrospective study of 203 adults in the United States found that liver transplantation for unresectable colorectal liver metastases achieved a 48.9 percent survival rate at five years. The findings, based on data collected between 2017 and 2025, offer insights into treatment outcomes for this patient population.
Why it matters
Understanding post-transplant survival helps clinicians refine patient selection and prioritize graft types for those managing advanced colorectal cancer. This study provides a national perspective on outcomes that can inform future care decisions for patients facing limited treatment options.
Researchers analyzed data from 203 adults with a mean age of 49.6, tracking survival through March 2026. The study reported 1-year, 3-year, and 5-year survival rates of 90.9%, 69.8%, and 48.9%, respectively.
The players
Scientific Registry of Transplant Recipients
An organization that maintains a national database of organ transplant data in the United States to support clinical research and public health oversight.
The details
The study utilized data from the Scientific Registry of Transplant Recipients to examine outcomes for patients whose colorectal cancer had spread to the liver. Surgeons performed transplants on patients with a median MELD score of 8, with 41.4% of the organs coming from living donors. Following surgery, patients experienced a median hospital stay of 8 days, though malignancy-related issues remained the primary cause of death among those who did not survive the study period.
Timeline
2017-2025: Participants received liver transplants during this period.
March 2026: The study follow-up period concluded.
Health Landscape
This research contributes to the growing body of literature evaluating the role of transplantation in treating previously unresectable liver metastases. It follows established patterns set by data within the Scientific Registry of Transplant Recipients to refine survival expectations.
If you are managing colorectal cancer with liver metastases, these findings represent an area of study worth discussing with your oncology team. Consider asking your physician about the clinical criteria used to determine transplant candidacy and how survival statistics apply to your specific health profile.
The takeaway
While liver transplantation offers a survival pathway for some patients with unresectable liver metastases, the procedure carries risks related to cancer recurrence. Patients should work with a multidisciplinary care team to track recurrence markers and stay informed on updated transplant guidelines.
Further reading
For more on evolving treatment options and current research, explore our Cancer section.
Source note: This article includes information reported by Healio.
Live Poll
Should specialized transplant treatments for rare cancers receive broader focus in national healthcare?
